Endpoint definition
↥| Name | D3_IMMUDEF |
|---|---|
| Long name | Immunodeficiencies |
| Include | D3_IMMUDEFANTIBODY, D3_COMBIMMUDEF, D3_IMMUDEFWITHMAJORDEF, D3_CVID, D3_IMMUDEFOTHER, D3_KELA_IMMUDEF |
| Level in the ICD-hierarchy | C |
| First defined in version | DF2 |
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 703 | 470 | 233 |
| Unadjusted prevalence (%) | 0.32 | 0.38 | 0.25 |
| Mean age at first event (years) | 47.92 | 47.08 | 49.60 |
| Case fatality at 5-years (%) | 3.70 | 4.04 | 3.00 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 2.0 | 2.0 | 1.0 |
| Recurrence at 6 months (%) | 48.93 | 51.06 | 44.64 |
Survival analyses between endpoints
↥Plot
before Immunodeficiencies
after Immunodeficiencies
Loading survival analyses plot…
Table
Loading survival analyses table…